a5466788.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15 (d) of the
Securities
Exchange Act of 1934
AUGUST
7,
2007
Date
of
Report (Date of earliest event reported)
CHARLES
RIVER LABORATORIES INTERNATIONAL, INC.
(Exact
Name of Registrant as specified in its Charter)
Delaware
|
|
333-92383
|
|
06-1397316
|
(State
or Other Jurisdiction of
Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer Identification
No.)
|
251
Ballardvale Street
Wilmington,
Massachusetts 01887
(Address
of Principal Executive Offices) (Zip Code)
978-658-6000
(Registrant's
Telephone Number, including Area Code)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|_| Written
communications pursuant to Rule 425 under the Securities Act
(17 CFR
230.425)
|_| Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
|_| Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
|_| Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
ITEM
2.02. Results of Operations and Financial Condition
The
following information shall not be deemed "filed" for purposes of Section 18
of
the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set forth by specific
reference in such a filing.
On
August
7, 2007, Charles River Laboratories International, Inc. issued a press release
providing financial results for the quarter ended June 30, 2007.
The
press
release, attached as an exhibit to this report, includes "safe harbor" language
pursuant to the Private Securities Litigation Reform Act of 1995, as amended,
indicating that certain statements contained in the press release are
"forward-looking" rather than historic. The press release also states that
these
and other risks relating to Charles River are set forth in the documents filed
by Charles River with the Securities and Exchange Commission.
ITEM
9.01. Financial Statements and Exhibits
(a) Not
applicable.
(b) Not
applicable.
(c) Exhibits.
99.1 Press
release
dated August 7, 2007.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended,
we
have
duly caused this report to be signed on its behalf by the undersigned
hereunto
duly authorized.
|
CHARLES
RIVER LABORATORIES
INTERNATIONAL,
INC.
|
Dated:
August 7, 2007
By:
/s/
Joanne P. Acford
Joanne
P.
Acford, Corporate Senior Vice
President,
General Counsel and
Corporate
Secretary
Exhibit
Index
Exhibit
No.
|
|
Description
|
|
|
|
|
99.1
|
|
Press
release dated August 7, 2007.
|
4